Kezar Life Sciences, Inc. (KZR) Tops Q3 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q3 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Netskope, Inc. (NTSK) Tops Q2 EPS by 4c, Offers Guidance
• Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue